The Lancet's Dara Mohammadi speaks to David Sampson, one of the authors of the 2012 Access to Medicine Index, about the 2012 Index findings.
In the Media
View:
The Lancet News interviews co-author of the Access to Medicine Index on 2012 findings
30 November 2012 |
Kaiser Family Foundation Global Health Policy Report features the 2012 Access to Medicine Index
28 November 2012 |
The Kaiser Family Foundation presents the main findings of the 2012 Access to Medicine Index as part of its Daily Global Health Policy Report.
NOS interviews Wim Leereveld about the 2012 Access to Medicine Index
28 November 2012 |
Dutch national news broadcaster NOS interviews Wim Leereveld, founder and CEO of the Access to Medicine Foundation, about the 2012 Access to Medicine Index findings and reports on a related neo-natal resuscitation training programme in India.
Financial Times discusses clinical trial outsourcing following the launch of the 2012 Access to Medicine Index
28 November 2012 |
Andrew Jack reports on the 2012 Access to Medicine Index findings, highlighting the Index conclusion that there is room for improvement in pharmaceutical companies' accountability for the behaviour of Contract Research Organisations (CROs).
Lancet Oncology highlights Access to Medicine Index
14 January 2013 |
In a Lancet Oncology editorial from January 14th, 2013, the Access to Medicine Index is mentioned in the context of the growing burden of non-communicable diseases like cancer in developing countries.
Financial Times Africa asks the Foundation about GSK and clinical trials
24 April 2013 |
Adam Green discusses the changing relationship between big pharma and emerging markets in this FT.com blog. The article first brings up the Access to Medicine Index and GlaxoSmithKline's #1 ranking in 2012 before moving on to discuss various aspects of GSK's access to medicine strategies and its approach to clinical trials with, among others, Tara Prasad of the Access to Medicine Foundation's research team.
The Guardian includes Access to Medicine Index in article about the donations debate
29 April 2013 |
The Guardian's Adam Robert Green reports on the ways in which views of drug donations and alternative initiatives are changing within the pharmaceutical industry and among the industry's partners. The 2012 Access to Medicine Index is mentioned along with some of the top ranked companies in the 2012 Index in the context of measuring the trend towards collaboration and alternative solutions.
Access to Medicine Index findings featured by UN Millenium Development Goals tracker
5 December 2012 |
The United Nations Integrated Implementation Framework reports the 2012 Access to Medicine Index findings. These findings can be particularly relevant for Millenium Development Goals (MDGs) concerning maternal health, child mortality and diseases such as HIV/AIDS and malaria.
Novethic discusses 2012 Access to Medicine Index findings
29 November 2012 |
Novethic reports on the 2012 Index ranking, citing progress made by the pharmaceutical industry as well as areas for improvement.
Morningstar.nl highlights investment aspects of access to medicine
29 November 2012 |
The 2012 Access to Medicine Index ranking is featured on the Dutch Morningstar page, in combination with analysis from Morningstar's own editors.
FDA reports on Access to Medicine Index
29 November 2012 |
The Food and Drug Administration, the main public health regulatory agency in the US, reports on the findings of the 2012 Access to Medicine Index in its Drug Industry Daily newsletter.
Swiss Public Radio interviews David Sampson about the 2012 Access to Medicine Index
8 December 2012 |
David Sampson, one of the 2012 Access to Medicine Index authors, speaks to Swiss Public Radio about the 2012 Index findings.
SciDev Net features Access to Medicine Index findings
30 November 2012 |
SciDev.Net, a global network providing information about science and technology in the developing world, discusses the 2012 Access to Medicine Index findings. The article pays particular attention to concerns and positive trends with regards to Research & Development.
El País discusses Access to Medicine Index
10 December 2012 |
The Spanish newspaper El País reports on the findings of the Access to Medicine Index, highlighting industry progress as well as areas for future improvement.
New York Times reports on 2012 Access to Medicine Index findings
4 December 2012 |
Donald McNeil, Jr. writes about the company rankings in the 2012 Access to Medicine Index.
Wim Leereveld featured on Casa Luna
30 November 2012 |
Frank du Mosch interviews Wim Leereveld, CEO and founder of the Access to Medicine Foundation, about the Access to Medicine Index.
Volkskrant reports on the Access to Medicine Index
28 November 2012 |
Carlijne Vos writes about the 2012 Access to Medicine Index results and the pharmaceutical industry's movement towards better access to medicine practices.
Voice of Russia discusses drug trials in the developing world
28 November 2012 |
Voice of Russia interviews Wim Leereveld about the 2012 Access to Medicine Index findings, including the issue of pharmaceutical company oversight when it comes to clinical trials conducted by third parties.
Wim Leereveld appears as guest on Pauw & Witteman talk show
28 November 2012 |
Pauw & Witteman, a nightly Dutch talk show about current affairs, interviews Wim Leereveld about the creation of the Access to Medicine Index and the 2012 results.
L'Express highlights French pharmaceutical company's rise in the 2012 Access to Medicine Index
28 November 2012 |
French magazine L'Express reports on Sanofi moving up to 3rd place in the 2012 Access to Medicine Index.
PharmaTimes reports on pharmaceutical companies leading the way in access to medicine
28 November 2012 |
Kevin Grogan discusses the performance of the leading pharmaceutical companies in the 2012 Access to Medicine Index, along with Index findings about the areas in which the pharmaceutical industry could step up its efforts.
The Guardian reports on pharmaceutical industry progress
28 November 2012 |
Sarah Boseley reports on the findings of the 2012 Access to Medicine Index, including the ways in which pharmaceutical companies have increased their efforts to improve access to medicine.
Reuters reports on pharmaceutical companies' increased focus on access to medicine
28 November 2012 |
Ben Hirschler reports on the launch of the 2012 Access to Medicine Index, highlighting the overall improvements made by pharmaceutical companies since the publication of the 2010 Index.
BBC highlights concerns about CROs
28 November 2012 |
Jane Dreaper writes about the 2012 Access to Medicine Index results, including the concerns surrounding pharmaceutical companies' use of Contract Research Organisations (CROs) to outsource clinical trials.
The Access to Medicine Index recognised as a tool for healthcare investors
27 November 2012 |
The Financial Times Adviser published an analysis of the changing investment landscape of the pharmaceutical industry, in which the Access to Medicine Index is mentioned "a useful tool to help differentiate between company approaches".
Neglected diseases 'Vergeten ziekte wordt bekend'
6 March 2012 |
Last January's London Declaration on Neglected Tropical Diseases, was covered in international media such as The Guardian. The Dutch daily newspaper 'De Volkskrant' also headlined the vision for 2020 to eradicate neglected diseases and the Access to Medicine Foundation was asked to comment on these developments.
TV Documentary 'Patents or Patients?'
20 July 2011 |
On 20 and 27 July, the Access to Medicine Index and Wim Leereveld, are featured in a Dutch documentary about access to medicine in developing countries. Gideon Levy, an award-winning reporter, investigates how it is possible that two billion people lack access to medicine.
His question is triggered by the current controversial EU Trade Agreement with India, which has implications on generic medicine availability in the developing world. He travels to Uganda and talks with HIV-AIDS patients, who are mostly dependent on cheaper generic medicines from India.
With this program Levy provides an accessible breakdown of this complex issue for the public. He takes into account the views of relevant stakeholders: among others he talks to EU politicians and policy makers, GlaxoSmithKline, AVIVA, Nefarma and Médicins sans Frontières. The Access to Medicine Index is viewed by Levy as an instrument of change that stimulates pharmaceutical companies to do more for developing countries.
Gideon Levy is winner of the prestigious European broadcast award ‘Prix Europa 2009’ for ‘Lockerbie Revisited’.
Catch Up Opportunity 'Patents or Patients?'
Catch up opportunity of Part 1 and Part 2 in Dutch ('Laatste uitzending gemist?')We have an English subtitled version available for you, please contact mkavanagh@atmindex.org and we'll be happy to provide you with a link.
Broadcasting date and time
Documentary ‘Levy: Slikken of Stikken?’Wednesdays, 20 & 27 July 2011, 21:20 h (CET) NED 2, AVRO (National Dutch Television)
Support
Read more about the role of Cordaid's support of the Access to Medicine Foundation.
'Changing pharma'
4 July 2011 |
Interview in the July issue of 'P+' - People, Planet, Profit - the Dutch monthly magazine on corporate social responsibility, with Wim Leereveld. The theme of the magazine is the psychology behind persuasiveness. The interview with Wim focusses on his story how he convinced others of the power of the idea of the Access to Medicine Index, to catalyst change in the pharmaceutical companies and stimulate them to enhance access to medicine in developing countries.
'GSK Makes a Good Impression with Lower Priced Vaccines'
13 June 2011 |
Was headlined in the Dutch daily newspaper 'De Volkskrant'. The article featured the recent announcements of pharmaceutical companies GSK, Merck and Sanofi-Aventis to lower their prices of vaccines in developing countries and the first time that UNICEF publicly listed the price it pays for vaccines. The Access to Medicine Index, in the person of Wim Leereveld was asked to comment. You can find the Dutch article at 'Downloads'.
'Big Pharma Is Changing Under Pressure'
30 May 2011 |
On the 27th of May, 'De Volkskrant', a leading Dutch daily, reports on how pharmaceutical companies are challenged by the Access to Medicine Index to do more on access to medicine in the developing countries. Last week, May 24th, the 'Index' pharma companies gathered in Amstelveen (The Netherlands), to discuss the data collection process around the Index 2012. “Societal pressure for sustainable and social production is so high now, you have to deal with it as a company. Shareholders also want stable and sustainable results and are taking an ever increasing amount of interest in public opinion. In this context, the Index is a major driving force”, says Sophia Tickell (Chair of the 'Amstelveen' meeting and founder of the PharmaFutures-series), when talking about the power of the Index. Read more about what GSK and Pfizer are doing on access to medicine in the full article at 'Downloads'.
The Al Gore of the Pharmaceutical Industry?
26 May 2011 |
On May 24th, Harmke Pijpers of BNR - Business News Radio - interviewed Wim Leereveld about the Access to Medicine Index. Harmke introduced Wim to the audience as the 'Al Gore of the pharmaceutical industry', to illustrate the drive he still has after 8 years to encourage the world's largest pharma companies to do more for 2 billion people who lack access to medicine. To listen to the full interview, click here.
'Reward Big Pharma for Good Behaviour'
17 May 2011 |
In NRC Next, Wim Leereveld's opiniated article, on how to influence pharmaceutical companies policies and practices to increase access to medicine, was published. NRC Next is a Dutch daily, that specifically targets a younger, well educated audience. The article refers to 'Morgen 2011' (Tomorrow 2011), where Wim is one of speakers at May 21, 2011.
'Sociale farmaceut beter geleid'
13 May 2011 |
One of the leading Dutch newspapers, De Telegraaf, covered the news about APG and ASN Bank signing the investor statement of the Access to Medicine Index. Both APG, one of the world's largest pension asset managers and ASN Bank, the largest sustainable bank in the Netherlands, use the information in the Index when making investment decisions concerning pharmaceutical companies.
Need some help?
27 January 2011 |
The Dutch magazine for international development - 'Vice Versa' - gives an overview of American funding for Dutch development organizations. The Access to Medicine Foundation is mentioned as one of the organizations who receives funding from the Bill and Melinda Gates Foundation. In the article you will find an interesting graphic on the numbers of American funding in the Netherlands.
'This work really can make a difference'
21 January 2011 |
C2W Medicines, an independent Dutch magazine on pharmaceutical research, published a cover story in the December issue on Wim Leereveld, Chairman of the Access to Medicine Foundation. It is an inspirational story about one man's drive to make the Index a reality. "This isn't about money. The work is much more satisfying and really can make a difference."
Demonstrating Impact: Access to Medicine: Malaria Treatment
21 September 2010 |
Improving access to medicine can have powerful and positive effects for individuals around the world that suffer from preventable illness and disease. By simply making medicines available and cost-effective we can improve the lives of an estimated 2 billion individuals worldwide that still lack access to essential medicines. Please watch the following video and visit the Global Poverty website to understand more how improving access to medicine can save lives and reduce suffering.
Wim Leereveld Featured on NieuwWij
19 September 2010 |
Wim Leereveld wil via Access to Medicine Index farmabedrijven mobiliseren
24 July 2010 |
Elk jaar in juni komen op het Pacific Health Summit internationale topbestuurders van overheden, wetenschap en bedrijfsleven bijeen om met elkaar te discussiëren over wegen en mogelijkheden die ‘de wereld gezonder maken’. Het was op dát prestigieuze podium waar Haarlemmer Wim Leereveld de tweede editie van ‘zijn’ Access to Medicine Index presenteerde.
SRI blog
13 July 2010 |
Henderson hosted an investor seminar in early July on the investment implications of access to medicines (AtM), a common term used to describe company efforts to ensure access to their medicines by patients who need them.
DFID
12 July 2010 |
Access to medicine is a basic right, yet each year millions of people die due to preventable and treatable diseases such as HIV, malaria and tuberculosis.
Thai PR Net
6 July 2010 |
เมื่อเร็วๆ นี้ จีเอสเค หรือ บริษัทแกล็กโซสมิทไคล์น ได้รับการจัดอันดับสูงสุดของดัชนีการเข้าถึงยา (The Access to Medicine Index) หรือ AMI ประจำปี พ.ศ. 2553 โดยมูลนิธิเพื่อการเข้าถึงยา (The Access to Medicine Foundation) ซึ่งเป็นองค์กรระหว่างประเทศที่ไม่แสวงหาผลกำไร มีสำนักงานใหญ่ในประเทศเนเธอร์แลนด์ มีจุดมุ่งหมายหลักคือ ความพยายามให้เกิดการพัฒนาเพื่อให้ประชาชนและผู้ป่วยในประเทศกำลังพัฒนามีการเข้าถึงยาและวัคซีนได้มากขึ้น โดยจีเอสเคได้รับการจัดอันดับสูงสุดของ AMI อีกครั้งหลังจากที่ได้เป็นครั้งแรกใน พ.ศ. 2551 มาแล้ว
Brabants Dagblad
6 July 2010 |
Tijdens het WK-voetbal komt Afrika rechtstreeks in onze huiskamer. Soms zien we tussen de voetbalwedstrijden door iets van de ellende waarin veel Afrikanen nog steeds verkeren.
Financial Daily
5 July 2010 |
Europe-based pharmaceuticals groups are outperforming United States and Japanese rivals in efforts to ensure medicines reach the poor, says an independent evaluation published by the Financial Times. GSK a UK-based pharmaceutical company retained its prime position in second Access to Medicines Index, Merck of US, known for its efforts on HIV and donations to treat river blindness, came next, ahead of Novartis, Gilead and Sanofi-Aventis.
WSJ Health Blog
4 July 2010 |
A Different Kind of Ranking: A program that assesses pharma companies according to the drug access they provide to the world’s poor gives GlaxoSmithKline, Merck and Novartis its highest rankings, the NYT reports.
DNA India
2 July 2010 |
A study by the Netherlands-based non-profit organisation Access to Medicine Foundation has highlighted that GlaxoSmithKline, Merck and Novartis are leading attempts to make medicines available to people in developing countries.
Policy and Medicine
2 July 2010 |
Recent settlements, hearings, legal cases and congressional investigations have overshadowed one of the most important roles pharmaceutical companies play in the world: making their products available to the world’s poor.
DNAIndia
2 July 2010 |
A study by the Netherlands-based non-profit organisation Access to Medicine Foundation has highlighted that GlaxoSmithKline, Merck and Novartis are leading attempts to make medicines available to people in developing countries.
Bill Gates-What I'm Thinking
2 July 2010 |
For people suffering from serious but treatable diseases like pneumonia and tuberculosis, access to drugs can mean the difference between life and death. A new report and two recent announcements are signs of progress in efforts to expand access.
Economist
2 July 2010 |
The Access to Medicine Index,
which is funded by governments and charities, including the Gates foundation, published a study on the efforts of 27 drug companies to provide medicine to the developing world.
The New York Times
28 June 2010 |
GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world’s poor.